The suspension of trading in the securities of Imagion Biosystems Limited (‘IBX’) will be lifted immediately, following the release by IBX of an announcement regarding a proposed capital raising.
View the Reinstatement to Official Quotation announcement.
Positive independent review sets priority path to market for MagSense® Technology
February 5, 2023
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance